Based on the significantly decreased edema volume and reduced risk for haemorrhagic transformation upon anti-OPN antibody treatment after ischemic stroke in mice, we evaluated the effects of the OPN neutralizing therapy on NVU cells and in particular on BBB function. This evidence concerns the gene SPP1 and ischemic stroke.